Xiaoyan Luo

Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial.

Chuanyue Wang, Qiang Wang, Huafang Li, 2015, Journal of psychiatric research.

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

Ying Cheng, B. Han, He-long Zhang, 2016, BMC Cancer.

Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects

Chaoying Hu, Chen Yu, Jingying Jia, 2017, Clinical Drug Investigation.

High loading-dose of dupilumab resulted in rapid disease control in pediatric patients with atopic dermatitis

Wei Li, Yang Luo, Yuan-yuan Zhou, 2023, Frontiers in Immunology.

Randomized, double‐blind, 6‐week non‐inferiority study of lurasidone and risperidone for the treatment of schizophrenia

W. Deng, Xiufeng Xu, Gang Wang, 2019, Psychiatry and clinical neurosciences.

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer

Ying Cheng, B. Han, He-long Zhang, 2016, BMC Cancer.